{
    "eid": "2-s2.0-85144976655",
    "title": "Novel xeno-free and serum-free culturing condition to improve piggyBac transposon-based CD19 chimeric antigen receptor T-cell production and characteristics",
    "cover-date": "2023-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Genetics (clinical)",
            "@code": "2716",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cell Biology",
            "@code": "1307",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Transplantation",
            "@code": "2747",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "CD19",
        "Chimeric antigen receptor T cells",
        "Fetal bovine serum",
        "Human AB serum",
        "PiggyBac transposon",
        "Serum replacement reagent"
    ],
    "authors": [
        "Mulita Sanyanusin",
        "Suparat Tudsamran",
        "Rattapoom Thaiwong",
        "Supannikar Tawinwung",
        "Nobuhiro Nishio",
        "Yoshiyuki Takahashi",
        "Nattiya Hirankarn",
        "Koramit Suppipat"
    ],
    "citedby-count": 1,
    "ref-count": 31,
    "ref-list": [
        "An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer",
        "Evolution of chimeric antigen receptor (CAR) T cell therapy: current status and future perspectives",
        "Early and late hematologic toxicity following CD19 CAR-T cells",
        "The market for chimeric antigen receptor T cell therapies",
        "GMP CAR-T cell production",
        "piggyBac-ing models and new therapeutic strategies",
        "PiggyBac-engineered T cells expressing CD19-specific CARs that lack IgG1 Fc spacers have potent activity against B-ALL xenografts",
        "Enhanced expression of anti-CD19 chimeric antigen receptor in piggyBac transposon-engineered T cells",
        "Guidance on good cell culture practice: a report of the second ECVAM task force on good cell culture practice",
        "A consensus introduction to serum replacements and serum-free media for cellular therapies",
        "Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells",
        "Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches",
        "Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications",
        "Human platelet lysate efficiency, stability, and optimal heparin concentration required in culture of mammalian cells",
        "Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity",
        "Human platelet lysate media supplement supports lentiviral transduction and expansion of human T lymphocytes while maintaining memory phenotype",
        "Enhancing chimeric antigen receptor T cell anti-tumor function through advanced media design",
        "Improved expansion and in vivo function of patient T cells by a serum-free medium",
        "Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cells",
        "Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy",
        "Closely related T-memory stem cells correlate with in vivo expansion of CAR. CD19-T cells and are preserved by IL-7 and IL-15",
        "T cell maturation stage prior to and during GMP processing informs on CAR T cell expansion in patients",
        "Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS immune cell serum replacement",
        "Xeno-free serum replacement for ex vivo culture and expansion of T cells",
        "Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype",
        "Naive human T cells can be a source of IL-4 during primary immune responses",
        "Promotion of human T lymphocyte proliferation by IL-4",
        "Biological properties of human interleukin-4",
        "Evaluation of nonviral piggybac and lentiviral vector in functions of CD19chimeric antigen receptor T cells and their antitumor activity for CD19+ tumor cells",
        "CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?",
        "Two subsets of memory T lymphocytes with distinct homing potentials and effector functions"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199584",
            "affilname": "Chulalongkorn Cancer Immunotherapy Excellence Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199584",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nagoya",
            "@id": "60161458",
            "affilname": "Nagoya University Graduate School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60161458",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Nagoya",
            "@id": "60024818",
            "affilname": "Nagoya University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024818",
            "affiliation-country": "Japan"
        }
    ],
    "funding": [
        "Thailand Research and Innovation Fund Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}